Literature DB >> 7063089

[Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)].

E Ringwald, D Hirt, R Markstein, J M Vigouret.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7063089

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

1.  Classification of drugs according to receptor binding profiles.

Authors:  A Closse; W Frick; A Dravid; G Bolliger; D Hauser; A Sauter; H J Tobler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

2.  Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.

Authors:  H Biesemeyer; H P Ludin; E Ringwald
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

3.  Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.

Authors:  H Baas; E Schneider; P A Fischer; G Japp
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Mesulergine in early Parkinson's disease: a double blind controlled trial.

Authors:  E Dupont; B Mikkelsen; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

5.  Dopaminergic properties of mesulergine (CU 32-085) and its metabolites.

Authors:  A Enz; P Donatsch; R Nordmann
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

6.  Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.

Authors:  K Jellinger
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.